SML0289

Bromfenac sodium

≥98% (HPLC)

• 동의어(들): 2-Amino-3-(4-bromobenzoyl)benzeneacetic acid sodium salt
• 실험식(Hill 표기법): C₁₅H₁₁BrNNaO₃
• CAS Number: 91714-93-1
• Molecular Weight: 356.15
• MDL number: MFCD03701673
• UNSPSC 코드: 12352200
• PubChem Substance ID: 329825297
• NACRES: NA.77

속성

• Quality Level: 100
• 분석: ≥98% (HPLC)
• 양식: powder
• 저장 조건: desiccated
• 색상: faintly yellow to dark yellow
• solubility: H₂O: ≥5 mg/mL
• 저장 온도: 2-8°C
• SMILES string: [Na+].Nc1c(CC([O-])=O)cccc1C(=O)c2ccc(Br)cc2
• InChI: 1S/C15H12BrNO3.Na/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19;/h1-7H,8,17H2,(H,18,19);/q;+1/p-1
• InChI key: HZFGMQJYAFHESD-UHFFFAOYSA-M
• 유전자 정보: human ... PTGS1(5742), PTGS2(5743)

설명

애플리케이션

Bromfenac sodium has been used:

• to study its ability to bind to melanin
• in the synthesis of bromfenac indolinone standard
• to analyze its permeability in porcine conjunctiva

생화학적/생리학적 작용

Bromfenac exhibits antipyretic and prostaglandin synthetase inhibiting properties. It has therapeutic properties against the reduction of ocular pain and inflammation in postoperative cataract patients. Bromfenac acts as an effective agent against allergic conjunctivitis. It has the potential to treat acute muscle pain, osteoarthritis, and rheumatoid arthritis.

Bromfenac is a nonsteroidal anti inflammatory drug (NSAID) that inhibits both COX1 and COX2. It is used as an opthalmic analgesic.

Bromfenac is a nonsteroidal anti inflammatory drug (NSAID); COX1 and COX2 inhibitor; opthalmic analgesic.

안전성 정보

• 픽토그램: GHS06
• 신호어: Danger
• 유해 및 위험 성명서: H301
• 예방조치 성명서: P264 - P270 - P301 + P310 - P405 - P501
• Hazard Classifications: Acute Tox. 3 Oral
• Storage Class Code: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable